Financials
Income statement
| Fiscal date | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 |
|---|---|---|---|---|
| Total reported revenue | — | 94.8B | 92.7B | 90.2B |
| Cost of revenue | — | 51.2B | 50.1B | 49.1B |
| Gross profit | — | 43.6B | 42.6B | 41.2B |
| Operating expense | ||||
| Research & development | — | — | — | — |
| Selling general and admin | — | — | — | — |
| Other operating expenses | — | — | — | — |
| Operating income | — | 9.5B | 10.4B | 9.5B |
| Non operating interest income | ||||
| Income | — | 1.0B | 976M | 771M |
| Expense | — | 41M | 32M | 34M |
| Other income expense | — | — | — | — |
| Pretax income | — | 8.2B | 11.1B | 10.1B |
| Tax provision | — | 2.5B | 2.8B | 2.0B |
| Net income | — | 5.7B | 8.3B | 8.1B |
| Basic EPS | 32.9 | — | — | — |
| Diluted EPS | 32.5 | — | — | — |
| Basic average shares | 281.0M | — | — | — |
| Diluted average shares | 284.8M | — | — | — |
| EBITDA | — | 14.9B | 15.6B | 14.6B |
| Net income from continuing op. | — | 8.2B | 11.1B | 10.1B |
| Minority interests | — | -19M | -38M | -21M |
| Preferred stock dividends | — | 0 | 0 | 0 |